Turning Proteins into DNA for Ultra-Sensitive Sequencing - Takeaway - MDSpire
From the Journals

Turning Proteins into DNA for Ultra-Sensitive Sequencing

Stanford researchers repurpose DNA sequencing technology to read proteins at single-molecule resolution, complementing – and potentially surpassing – mass spectrometry

  • April 2, 2026

  • 2 min

Share

  • 1

    New 'reverse translation' method converts proteins to DNA sequences.

  • 2

    Tags amino acids with DNA barcodes for sequencing.

  • 3

    Achieves ~98% accuracy with minimal sample requirements.

  • 4

    Detects rare peptides at low abundance (1 in a million).

  • 5

    Increases detection sensitivity compared to mass spectrometry.

  • 6

    Aims for push-button instrument for broader application.

  • 7

    Potential for comprehensive single-cell proteome mapping.

Original Source(s)

Turning Proteins into DNA for Ultra-Sensitive Sequencing

  • April 2, 2026

Related Content

Small Phase II Study Examines Triplet Regimen for Patients With HER2-Positive Breast Cancer and Leptomeningeal Metastasis

Results from a small phase II study suggest that a triplet regimen may improve symptoms and extend survival in some patients with breast cancer and leptomeningeal metastasis, who often face limited tr...

Antibody Oxidation’s Hidden Handedness Comes Into View

Integrated NMR and LC-MS analysis distinguishes elusive stereochemical forms of methionine oxidation in IgG1 Fc regions, offering a sharper tool for biologic drug quality control

  • April 8, 2026

  • 2 min
Analysis Shows Nearly 7% of Global Clinical Trials Are Impacted by Middle East Disruption

Oncology trials account for a substantial proportion of impacted activity, with non–small cell lung cancer representing the most affected indication, followed by breast cancer.